Coronary Artery Calcification in Rheumatoid Arthritis Patients: A Systematic Review

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2024 Oct 31

PMID 39479072

Authors

Stephanie Nagy

Jordan Ditchek

Marc M Kesselman

Affiliations

Soon will be listed here.

Abstract

Rheumatoid arthritis (RA) is one of the leading autoimmune causes of inflammatory arthropathy worldwide. The musculoskeletal impacts of RA are well described within the literature. More recently, research efforts have highlighted that inflammation associated with the condition is not solely isolated to the joint synovium. Specifically, data has demonstrated that the cardiovascular system is negatively impacted by inflammation tied to RA, with adverse cardiovascular outcomes considered the leading cause of mortality among patients with RA. One approach to determine the risk for cardiovascular disease (CVD) is computed tomography (CT) coronary angiography, a noninvasive imaging approach that analyzes the calcifications within the coronary vessels. This has increasingly been utilized to analyze plaque burden and vessel obstruction, which is measured using the coronary artery calcium (CAC) score. A total of 305 articles were analyzed, and 11 articles were selected for this review based on inclusion and exclusion criteria. The results indicated that nearly 60% of patients with RA experienced an elevated CAC score. As such, patients with RA likely carry a higher risk for adverse cardiovascular outcomes as compared to their healthy counterparts. Additional research is warranted based on these findings to determine whether the addition of CT coronary angiography and analysis of laboratory markers for CVD, including lipid markers in standard protocols for RA comorbid assessment, would help to reduce adverse cardiovascular complications.

References

Paccou J, Renard C, Liabeuf S, Kamel S, Fardellone P, Massy Z . Coronary and abdominal aorta calcification in rheumatoid arthritis: relationships with traditional cardiovascular risk factors, disease characteristics, and concomitant treatments. J Rheumatol. 2014; 41(11):2137-44. DOI: 10.3899/jrheum.140239. View

Megens R, Vijayan S, Lievens D, Doring Y, van Zandvoort M, Grommes J . Presence of luminal neutrophil extracellular traps in atherosclerosis. Thromb Haemost. 2012; 107(3):597-8. DOI: 10.1160/TH11-09-0650. View

Jesson C, Bohbot Y, Soudet S, Renard C, Sobhy Danial J, Diep L . Is the Calcium Score Useful for Rheumatoid Arthritis Patients at Low or Intermediate Cardiovascular Risk?. J Clin Med. 2022; 11(16). PMC: 9409866. DOI: 10.3390/jcm11164841. View

Tinggaard A, de Thurah A, Andersen I, Riis A, Therkildsen J, Winther S . Rheumatoid Arthritis as a Risk Factor for Coronary Artery Calcification and Obstructive Coronary Artery Disease in Patients with Chest Pain: A Registry Based Cross-Sectional Study. Clin Epidemiol. 2020; 12:679-689. PMC: 7322143. DOI: 10.2147/CLEP.S251168. View

Luo P, Wang P, Xu J, Hou W, Xu P, Xu K . Immunomodulatory role of T helper cells in rheumatoid arthritis : a comprehensive research review. Bone Joint Res. 2022; 11(7):426-438. PMC: 9350707. DOI: 10.1302/2046-3758.117.BJR-2021-0594.R1. View

. Global, regional, and national burden of rheumatoid arthritis, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023; 5(10):e594-e610. PMC: 10546867. DOI: 10.1016/S2665-9913(23)00211-4. View

Agca R, Heslinga S, Rollefstad S, Heslinga M, McInnes I, Peters M . EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis. 2016; 76(1):17-28. DOI: 10.1136/annrheumdis-2016-209775. View

Solomon D, Greenberg J, Curtis J, Liu M, Farkouh M, Tsao P . Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: a Consortium of Rheumatology Researchers of North America Registry Study. Arthritis Rheumatol. 2015; 67(8):1995-2003. DOI: 10.1002/art.39195. View

Namas R, Joshi A, Ali Z, Al Saleh J, Abuzakouk M . Demographic and Clinical Patterns of Rheumatoid Arthritis in an Emirati Cohort from United Arab Emirates. Int J Rheumatol. 2019; 2019:3057578. PMC: 6778867. DOI: 10.1155/2019/3057578. View

10.

Barbarroja N, Perez-Sanchez C, Ruiz-Limon P, Castro-Villegas C, Aguirre M, Carretero R . Anticyclic citrullinated protein antibodies are implicated in the development of cardiovascular disease in rheumatoid arthritis. Arterioscler Thromb Vasc Biol. 2014; 34(12):2706-16. DOI: 10.1161/ATVBAHA.114.304475. View

11.

Traish A, Bolanos J, Nair S, Saad F, Morgentaler A . Do Androgens Modulate the Pathophysiological Pathways of Inflammation? Appraising the Contemporary Evidence. J Clin Med. 2018; 7(12). PMC: 6306858. DOI: 10.3390/jcm7120549. View

12.

Primdahl J, Clausen J, Horslev-Petersen K . Results from systematic screening for cardiovascular risk in outpatients with rheumatoid arthritis in accordance with the EULAR recommendations. Ann Rheum Dis. 2013; 72(11):1771-6. DOI: 10.1136/annrheumdis-2013-203682. View

13.

Drosos G, Vedder D, Houben E, Boekel L, Atzeni F, Badreh S . EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome. Ann Rheum Dis. 2022; 81(6):768-779. DOI: 10.1136/annrheumdis-2021-221733. View

14.

Arts E, Popa C, den Broeder A, Donders R, Sandoo A, Toms T . Prediction of cardiovascular risk in rheumatoid arthritis: performance of original and adapted SCORE algorithms. Ann Rheum Dis. 2015; 75(4):674-80. DOI: 10.1136/annrheumdis-2014-206879. View

15.

Arts E, Popa C, den Broeder A, Semb A, Toms T, Kitas G . Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis. Ann Rheum Dis. 2014; 74(4):668-74. DOI: 10.1136/annrheumdis-2013-204024. View

16.

Karpouzas G, Malpeso J, Choi T, Li D, Munoz S, Budoff M . Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease. Ann Rheum Dis. 2013; 73(10):1797-804. DOI: 10.1136/annrheumdis-2013-203617. View

17.

Montes A, Corrales A, Calaza M, Lopez-Mejias R, Parra J, Gonzalez-Gay M . Brief report: lack of replication of an association between anti-citrullinated fibrinogen and subclinical atherosclerosis in patients with rheumatoid arthritis. Arthritis Rheumatol. 2015; 67(11):2861-5. DOI: 10.1002/art.39302. View

18.

Xiang D, Liu Y, Zhou S, Zhou E, Wang Y . Protective Effects of Estrogen on Cardiovascular Disease Mediated by Oxidative Stress. Oxid Med Cell Longev. 2021; 2021:5523516. PMC: 8260319. DOI: 10.1155/2021/5523516. View

19.

Andreini D, Pontone G, Bartorelli A, Agostoni P, Mushtaq S, Bertella E . Sixty-four-slice multidetector computed tomography: an accurate imaging modality for the evaluation of coronary arteries in dilated cardiomyopathy of unknown etiology. Circ Cardiovasc Imaging. 2009; 2(3):199-205. DOI: 10.1161/CIRCIMAGING.108.822809. View

20.

Dalbeni A, Giollo A, Bevilacqua M, Cioffi G, Tagetti A, Cattazzo F . Traditional cardiovascular risk factors and residual disease activity are associated with atherosclerosis progression in rheumatoid arthritis patients. Hypertens Res. 2020; 43(9):922-928. DOI: 10.1038/s41440-020-0441-1. View